Published in Cancer Res on May 01, 1990
Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br J Cancer (1992) 1.25
Polymeric drug delivery for the treatment of glioblastoma. Neuro Oncol (2015) 0.90
Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion. Cancer Cell Int (2012) 0.79
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide. Core Evid (2012) 0.79
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res (2001) 2.16
Ornithine decarboxylase is important in intestinal mucosal maturation and recovery from injury in rats. Science (1980) 1.61
Molecular mechanics of the interactions of spermine with DNA: DNA bending as a result of ligand binding. Nucleic Acids Res (1990) 1.46
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol (1997) 1.44
Implications and concepts of polyamine-nucleic acid interactions. J Cell Biochem (1991) 1.41
Polyamines: a high correlation with cell replication. FEBS Lett (1975) 1.36
Spermine-DNA interactions: a theoretical study. Proc Natl Acad Sci U S A (1986) 1.36
p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys (1996) 1.14
Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes. Biochem J (1990) 1.14
A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia (2001) 1.13
More sensitive automated detection of polyamines in physiological fluids and tissue extracts with omicron-phthalaldehyde. Clin Chem (1975) 1.13
The 9L rat brain tumor: description and application of an animal model. J Neurol (1981) 1.11
Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography. J Lab Clin Med (1980) 1.10
Conformationally restricted analogues of 1N,12N-bisethylspermine: synthesis and growth inhibitory effects on human tumor cell lines. J Med Chem (1998) 1.10
Molecular dynamics of spermine-DNA interactions: sequence specificity and DNA bending for a simple ligand. Nucleic Acids Res (1989) 1.09
Polyamines are necessary for the survival of human small-cell lung carcinoma in culture. Proc Natl Acad Sci U S A (1981) 1.07
Measurement of putrescine, spermidine, and spermine in physiological fluids by use of an amino acid analyzer. Clin Chem (1973) 1.07
Changes in L-ornithine decarboxylase activity during the cell cycle. Biochem Biophys Res Commun (1976) 1.06
Conformationally restricted analogues of 1N,14N-bisethylhomospermine (BE-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cells. J Med Chem (2001) 1.04
Effect of cell-cell interactions on drug sensitivity and growth of drug-sensitive and -resistant tumor cells in spheroids. Science (1984) 1.04
Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: the significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts. J Cell Physiol (1993) 1.03
The concept of drug dose for in vitro studies with chemotherapeutic agents. Radiat Res (1978) 1.01
Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res (1997) 1.00
Changes in polyamine metabolism in WI38 cells stimulated to proliferate. Exp Cell Res (1975) 1.00
Polyamine metabolism in a rat brain tumor cell line: its relationship to the growth rate. J Cell Physiol (1975) 1.00
Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review. J Natl Cancer Inst (1979) 0.99
Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer (1999) 0.99
Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res (2000) 0.98
Effects of extreme hypoxia on the growth and viability of EMT6/SF mouse tumor cells in vitro. Cancer Res (1983) 0.98
Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res (1993) 0.97
New DNA polymorphism: evidence for a low salt, left-handed form of poly(dG-m5dC). Nucleic Acids Res (1985) 0.96
A stopped-flow H-D exchange kinetic study of spermine-polynucleotide interactions. Nucleic Acids Res (1987) 0.96
Effect of methylglyoxal-bis (guanylhydrazone), an inhibitor of spermidine and spermine synthesis, on cell cycle traverse. Eur J Cancer (1977) 0.96
Growth regulatory effects of cyclic AMP and polyamine depletion are dissociable in cultured mouse lymphoma cells. J Cell Biol (1983) 0.96
Stabilization of erythrocyte membranes by polyamines. Proc Natl Acad Sci U S A (1983) 0.95
Correlation between the effects of polyamine analogues on DNA conformation and cell growth. Cancer Res (1989) 0.95
p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J Radiat Oncol Biol Phys (1999) 0.94
Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX. Neoplasia (1999) 0.94
Biphasic stimulation of polyamine biosynthesis in primary mouse kidney cells by infection with polyoma virus:uncoupling from DNA and rRNA synthesis. Proc Natl Acad Sci U S A (1976) 0.94
Simultaneous measurement of phenobarbital, phenytoin, primidone, ethosuximide, and carbamazepine in serum by high-pressure liquid chromatography. Clin Chem (1977) 0.93
Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res (1981) 0.93
Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones. Cancer Res (1997) 0.93
Depletion of 9L rat brain tumor cell polyamine content by treatment with D,L-alpha-difluoromethylornithine inhibits proliferation and the G1 to S transition. Exp Cell Res (1981) 0.93
A statistical approach for analyzing clonogenic survival data. Radiat Res (1996) 0.92
The interaction of spermine and pentamines with DNA. Biochem J (1987) 0.92
Polyamine content of AKR leukemic cells in relation to the cell cycle. Cancer Res (1973) 0.91
A new model for disruption of the ornithine decarboxylase gene, SPE1, in Saccharomyces cerevisiae exhibits growth arrest and genetic instability at the MAT locus. Biochem J (1995) 0.91
Differential effects of spermine and its analogues on the structures of polynucleotides complexed with ethidium bromide. Biochem J (1993) 0.91
Polyamines in clinical disorders. West J Med (1985) 0.91
Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res (1981) 0.90
Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay. Cancer Res (1986) 0.90
Characterization of human glioblastoma xenograft growth in athymic mice. In Vivo (1998) 0.90
Electron-phonon scattering in metal clusters. Phys Rev Lett (2003) 0.90
Retracted Polyamine depletion influences drug-induced chromosomal damage. Science (1982) 0.89
BCNU and X-ray therapy of intracerebral 9L rat tumors. Int J Radiat Oncol Biol Phys (1979) 0.89
Antizyme and antizyme inhibitor activities influence cellular responses to polyamine analogs. Amino Acids (2007) 0.89
Depletion of intracellular putrescine and spermidine by alpha-difluromethylornithine does not inhibit proliferation of 9L rat brain tumor cells. Biochem Biophys Res Commun (1979) 0.88
Depletion of intracellular polyamines may alter DNA conformation in 9L rat brain tumor cells. Science (1983) 0.88
Molecular basis of inward rectification: structural features of the blocker defined by extended polyamine analogs. Mol Pharmacol (2005) 0.88
Quantitative determination of the size dependence of surface plasmon resonance damping in single Ag@SiO(2) nanoparticles. Nano Lett (2009) 0.88
Recognition of Z-RNA and Z-DNA determinants by polyamines in solution: experimental and theoretical studies. J Biomol Struct Dyn (1988) 0.87
The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors. Cancer Res (1976) 0.87
BCNU-modification of the in vitro radiation response in 9L brain tumor cells of rats. Int J Radiat Oncol Biol Phys (1977) 0.86
Effect of polyamine depletion on chromatin structure in U-87 MG human brain tumour cells. Biochem J (1992) 0.86
The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer. Cancer Chemother Pharmacol (2009) 0.86
Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute. J Neurooncol (1993) 0.86
CSF polyamines: a new and important means of monitoring patients with medulloblastoma. Cancer (1981) 0.86
Comparison of clonogenic cell assays after in vivo and in vitro treatment of 9L gliosarcoma. Br J Cancer Suppl (1980) 0.85
Phase I-II clinical trial with alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis. Eur J Cancer Clin Oncol (1987) 0.85
Quantitative dose-response relations for the cytotoxic activity of chloroethylnitrosoureas in cell culture. Cancer Res (1982) 0.85
Development of a 9L rat brain tumor cell multicellular spheroid system and its response to 1,3-bis(2-chloroethyl)-1-nitrosourea and radiation. J Natl Cancer Inst (1980) 0.85
Factors influencing the recovery from potentially lethal damage (PLD) in mammalian cells in vitro and in vivo. Cancer Treat Rev (1980) 0.84
Increased polyamine concentrations in the cerebrospinal fluid of patients with brain tumors. Int J Cancer (1974) 0.84
Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro. Cancer Res (1982) 0.84
An automated micromethod for the quantitative analysis of di- and polyamines utilizing a sensitive high pressure liquid chromatographic procedure. FEBS Lett (1974) 0.84
Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs. Mol Pharmacol (1992) 0.84
cis-Unsaturated analogues of 3,8,13,18,23-pentaazapentacosane (BE-4-4-4-4): synthesis and growth inhibitory effects on human prostate cancer cell lines. J Med Chem (2001) 0.84
Relationship of urinary polyamines to tumor activity and tumor volume in patients. Cancer Res (1984) 0.83
Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation. Int J Radiat Oncol Biol Phys (1997) 0.83
Effect of feeder cell-released substances on the survival of clonogenic 9L cells after treatment with antimetabolites. Cancer Res (1980) 0.83
Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO). Radiat Res (1986) 0.82
Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int J Radiat Oncol Biol Phys (1999) 0.82
Effects of dicyclohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells. Cancer Res (1985) 0.82
Effect of N1,N14-bis(ethyl)homospermine on the growth of U-87 MG and SF-126 human brain tumor cells. Cancer Res (1990) 0.82
High-pressure liquid-chromatographic determination of 5-(4-hydroxyphenyl)-5-phenylhydantoin in humanurine. Clin Chem (1976) 0.82
Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo. Cancer Chemother Pharmacol (1998) 0.82